Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist

Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?

(2013) Carla M Prado et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Non-invasive assessment of cardiac hemodynamics in patients with advanced cancer and with chronic heart failure: a pilot feasibility study

(2013) Stephan von Haehling et al.   Archives of Medical Science

Mechanisms for fiber-type specificity of skeletal muscle atrophy

(2013) Yichen Wang et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia

(2013) Sandra Palus et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Translational implications of novel findings in cancer cachexia

(2013) Hirak Der-Torossian et al.   Current Opinion in Supportive and Palliative Care

Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery

(2012) J R Lieffers et al.   BRITISH JOURNAL OF CANCER

Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab

(2012) Heloisa Sawaya et al.   Circulation-Cardiovascular Imaging

Cachexia and Oxidative Stress in Cancer: An Innovative Therapeutic Management

(2012) Giovanni Mantovani et al.   CURRENT PHARMACEUTICAL DESIGN

Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)

(2012) S. Fulster et al.   EUROPEAN HEART JOURNAL

Advances in the Science and Application of Body Composition Measurement

(2012) Vickie Baracos et al.   JOURNAL OF PARENTERAL AND ENTERAL NUTRITION

Evaluation of the Clinical Relevance of Body Composition Parameters in Patients With Cancer Metastatic to the Liver Treated With Hepatic Arterial Infusion Chemotherapy

(2012) Henrique A. Parsons et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Body Composition, Symptoms, and Survival in Advanced Cancer Patients Referred to a Phase I Service

(2012) Henrique A. Parsons et al.   PLoS One

Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy

(2012) Paul W. Stoodley et al.   European Heart Journal-Cardiovascular Imaging

NF-κB Inhibition Protects against Tumor-Induced Cardiac Atrophy in Vivo

(2011) Ashley Wysong et al.   AMERICAN JOURNAL OF PATHOLOGY

Angiotensin II, Oxidative Stress and Skeletal Muscle Wasting

(2011) Sergiy Sukhanov et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors

(2011) C. Serrano et al.   ANNALS OF ONCOLOGY

Chemotherapy-induced cardiotoxicity

(2011) Daniela Di Lisi et al.   ANTI-CANCER DRUGS

Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer

(2011) Alexandre Cochet et al.   BREAST CANCER RESEARCH AND TREATMENT

Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity

(2011) Carla MM Prado et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Anthracycline cardiotoxicity

(2011) Pierantonio Menna et al.   Expert Opinion On Drug Safety

Mechanisms and management of doxorubicin cardiotoxicity

(2011) Y. Shi et al.   HERZ

Definition and classification of cancer cachexia: an international consensus

(2011) Kenneth Fearon et al.   LANCET ONCOLOGY

Pre-cachexia in patients with stages I–III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system

(2011) C.M. Op den Kamp et al.   LUNG CANCER

Oral Resveratrol Therapy Inhibits Cancer-Induced Skeletal Muscle and Cardiac Atrophy In Vivo

(2011) Scott Shadfar et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Cancer Induces Cardiomyocyte Remodeling and Hypoinnervation in the Left Ventricle of the Mouse Heart

(2011) Christian Mühlfeld et al.   PLoS One

The Regulation of Skeletal Muscle Protein Turnover during the Progression of Cancer Cachexia in the ApcMin/+ Mouse

(2011) James P. White et al.   PLoS One

The role of insulin resistance in the development of muscle wasting during cancer cachexia

(2011) Mary A. Honors et al.   Journal of Cachexia Sarcopenia and Muscle

Pitfalls in defining and quantifying cachexia

(2011) Vickie E. Baracos   Journal of Cachexia Sarcopenia and Muscle

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

(2010) S. Antoun et al.   ANNALS OF ONCOLOGY

Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies

(2010) Shontelle Dodson et al.   Annual Review of Medicine

Cancer Causes Cardiac Atrophy and Autophagy in a Sexually Dimorphic Manner

(2010) P. F. Cosper et al.   CANCER RESEARCH

Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival

(2010) Xiaolan Zhou et al.   CELL

The potential role of echocardiographic strain imaging for evaluating cardiotoxicity due to cancer therapy

(2010) Paul W. Stoodley et al.   Heart Lung and Circulation

Myocardial dysfunction in an animal model of cancer cachexia

(2010) Hui Xu et al.   LIFE SCIENCES

Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)

(2010) Stephan von Haehling et al.   Journal of Cachexia Sarcopenia and Muscle

A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands

(2009) Jessica R Lieffers et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis

(2009) G. Di Lorenzo et al.   ANNALS OF ONCOLOGY

Regulation and Function of NF-κB Transcription Factors in the Immune System

(2009) Sivakumar Vallabhapurapu et al.   Annual Review of Immunology

Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure

(2009) V. Lubrano et al.   BIOMEDICINE & PHARMACOTHERAPY

Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

(2009) B. H.L. Tan et al.   CLINICAL CANCER RESEARCH

Electrocardiographic Characterization of the QTc Interval in Patients with Advanced Solid Tumors: Pharmacokinetic- Pharmacodynamic Evaluation of Sunitinib

(2009) C. L. Bello et al.   CLINICAL CANCER RESEARCH

Recent insights on chronic heart failure, cachexia and nutrition

(2009) Alberto Miján-de-la-Torre   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice

(2009) Michelle L. Asp et al.   INTERNATIONAL JOURNAL OF CANCER

Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: Effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide

(2009) Mauro Feola et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Retrospective Analysis of the Safety and Efficacy of Interleukin-2 After Prior VEGF-targeted Therapy in Patients With Advanced Renal Cell Carcinoma

(2009) Daniel C. Cho et al.   JOURNAL OF IMMUNOTHERAPY

Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention

(2009) Adriana Albini et al.   JNCI-Journal of the National Cancer Institute

The pathophysiology of cardiac cachexia

(2009) Lisa M Freeman   Current Opinion in Supportive and Palliative Care

The emerging role of computerized tomography in assessing cancer cachexia

(2009) Carla MM Prado et al.   Current Opinion in Supportive and Palliative Care

Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate

(2008) M. L. Telli et al.   ANNALS OF ONCOLOGY

A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care

(2008) Marina Mourtzakis et al.   Applied Physiology Nutrition and Metabolism

State of the art: Using natriuretic peptide levels in clinical practice

(2008) Alan Maisel et al.   EUROPEAN JOURNAL OF HEART FAILURE

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

(2008) Carla MM Prado et al.   LANCET ONCOLOGY

Cardiac cachexia: A systematic overview

(2008) Stephan von Haehling et al.   PHARMACOLOGY & THERAPEUTICS

Cancer fatigue syndrome reflects clinically non-overt heart failure: an approach towards oncocardiology

(2008) Martin Schünemann et al.   Nature clinical practice. Oncology

Monitoring of Anthracycline-Induced Cardiotoxicity

(2007) Abigail Jannazzo et al.   ANNALS OF PHARMACOTHERAPY